午夜电影在线观看国产1区|国产在线19禁免费观看国产|最近更新中文字幕2019视频|久久 _996热re视频精品视频这里-国产黄视频在线播放-国产最新精品亚洲2024不卡-久久久香

Search

About Us

Core Team

An experienced and efficient international team from China and the United States.
  1. Dr. Hongqi Tian

    Dr. Hongqi Tian

    Founder, Chairman, Chief Executive Officer

    Dr. Hongqi Tian, the founder of Kechow Pharma, has over twenty years of experience in new drug development. During his time at Array Biopharmaceuticals Inc. in the U.S., he successfully developed four new compounds into preclinical and clinical studies. In 2014, he founded Shanghai Kechow Pharma, Inc. The company’s new anti-cancer drug, HL-085, developed with 100% independent intellectual property rights, is regarded as the best of its kind in this field. It is currently undergoing Phase I/II clinical trials simultaneously in China and the U.S. In addition, the drug has applied for more than 80 patents worldwide, with over 40 granted, and has published 40 articles.

Meanwhile, Kechow Pharma has a comprehensive R&D team that integrates discovery, clinical development, and registration. This team works closely and seamlessly together with technical experts in medicinal chemistry, biology, medicine, registration, pharmacovigilance, project management, and more. From the discovery stage to the preclinical and clinical stages, the team brings extensive practical experience in their respective fields. Currently, our growing R&D team consists of nearly 80 scientists and staff based in Shanghai, Beijing, and Tianjin, as well as international clinical and regulatory offices in the United States. Through our U.S.-based international team, we have been able to rapidly expand our international clinical development and regulatory approval operations.